Rezultati - Erika Florendo

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed By Ciltacabtagene Autoleucel Versus Vrd Followed By Lenalidomide and Dexamethasone (Rd) Maintenance in Patients with Newly Diagnosed Multiple Myeloma Not Intended for Transplant: A Randomized, Phase 3 Study (CARTITUDE-5)

    Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed By Ciltacabtagene Autoleucel Versus Vrd Followed By Lenalidomide and Dexamethasone (Rd) Maintenance in Patients with Newly... od Dominik Dytfeld, Binod Dhakal, Mounzer Agha, Salomon Manier, Michel Delforge, Steven Kuppens, Salma Afifi, William Deraedt, Agne Taraseviciute-Morris, Jordan M. Schecter, Jane Gilbert, Fevzi Fırat Yalniz, Erika Florendo, Lida Pacaud, Vânia Hungria, Saad Z. Usmani, María‐Victoria Mateos

    Izdano 2021
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma

    A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma od Ajai Chari, Hearn Jay Cho, Amishi Dhadwal, Gareth J. Morgan, Lisa La, Katarzyna Zarychta, Donna Catamero, Erika Florendo, Nadege Stevens, Daniel Verina, Elaine Chan, Violetta V. Leshchenko, Alessandro Laganá, Deepak Perumal, Anna Mei, Kaity Tung, Jami Fukui, Sundar Jagannath, Samir Parekh

    Izdano 2017
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: